EGFR and non-small cell lung carcinoma: The tandem-tip strategy identified differential site-specific glycosylation and phosphorylation from the highly relevant pathways, such as NSCLC, ErbB signaling pathway, and most well-known resistance-related EGFR TKI resistance pathway (Fig. 5D).